DHG Pharmaceutical Joint Stock Company reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was VND 1,534,725.36 million compared to VND 1,330,288.48 million a year ago. Net income was VND 261,115.71 million compared to VND 236,197.55 million a year ago. Basic earnings per share from continuing operations was VND 1,933 compared to VND 1,749 a year ago.
For the full year, revenue was VND 5,015,395.04 million compared to VND 4,676,016.01 million a year ago. Net income was VND 1,051,490.14 million compared to VND 988,454.65 million a year ago. Basic earnings per share from continuing operations was VND 7,786 compared to VND 7,318 a year ago.